• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Ambit Biosciences Corp

+ Add to Watchlist

AMBI:US

6.9400 USD 0.5300 8.27%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Ambit Biosciences Corp (AMBI)

Open: 6.4000 Day's Range: 6.4000 - 7.0300 Volume: 31,659
Previous Close: 6.4100 52wk Range: 5.7500 - 21.4400 1-Yr Rtn: -

Stock Chart for AMBI

No chart data available.
  • AMBI:US 6.9400
  • 1D
  • 1M
  • 1Y
6.4100
Interactive AMBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMBI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.9530
Est. PEG Ratio -
Market Cap (M USD) 124.73
Shares Outstanding (M) 17.97
30 Day Average Volume 69,820
Price/Book (mrq) 2.1119
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMBI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMBI

Ambit Biosciences Corporation operates as a biopharmaceutical company. The Company discovers and develops small molecule and orally administered enzyme inhibitors for the treatment of acute myeloid leukemia and inflammatory diseases. Ambit Biosciences operates in the United States.

Michael A MartinoPresident/CEOAlan FuhrmanChief Financial Officer
Athena CountouriotisChief Medical Officer
More Company Profile & Key Executives for AMBI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil